Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10780108 RNAi agents for Hepatitis B virus infection

Patent 10780108 was granted and assigned to Arrowhead Pharmaceuticals, Inc. on September, 2020 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 22 May, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 22 May, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=1078010800
Edits on 28 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 28 Apr, 2023
Edits on 25 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 25 Apr, 2023
Edits on 7 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 7 Apr, 2023
Edits on 29 Mar, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 29 Mar, 2023
Infobox
Is a
Patent
Patent
0
Patent Applicant
‌
Arrowhead Pharmaceuticals, Inc.
0
Current Assignee
‌
Arrowhead Pharmaceuticals, Inc.
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
107801080
Date of Patent
September 22, 2020
0
Patent Application Number
157660360
Date Filed
August 4, 2017
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=107801080
Patent Citations
‌
US Patent 10098959 Method for synthesis of reactive conjugate clusters
0
‌
US Patent 10130651 RNAi Therapy for Hepatitis B Virus Infection
0
‌
US Patent 10131907 Glycoconjugates of RNA interference agents
0
‌
US Patent 10246709 Targeting ligands for therapeutic compounds
0
‌
US Patent 10294474 Targeting ligands
0
‌
US Patent 10351852 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
0
‌
US Patent 10590418 Methods and compositions for RNAi mediated inhibition of gene expression in mammals
0
Patent Citations Received
‌
US Patent 11517584 RNAi agents for Hepatitis B virus infection
0
‌
US Patent 11534453 RNAi therapy for hepatitis B virus infection
0
‌
US Patent 11590156 RNAi agents for hepatitis B virus infection
0
Patent Primary Examiner
‌
J. E. Angell
0
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 28 Mar, 2023
Edits on 28 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 28 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 27 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 27 Mar, 2023
Edits on 26 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 26 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 25 Mar, 2023
Edits on 1 Mar, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 1 Mar, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11590156 RNAi agents for hepatitis B virus infection
0
Edits on 28 Dec, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 28 Dec, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11534453 RNAi therapy for hepatitis B virus infection
0
Edits on 7 Dec, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 7 Dec, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11517584 RNAi agents for Hepatitis B virus infection
0
Edits on 28 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 28 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 28 Sep, 2022
Edits on 27 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 27 Sep, 2022
Edits on 26 Sep, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 26 Sep, 2022
Infobox
Is a
Patent
Patent
0
Patent Applicant
‌
Arrowhead Pharmaceuticals, Inc.
0
Current Assignee
‌
Arrowhead Pharmaceuticals, Inc.
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
107801080
Date of Patent
September 22, 2020
0
Patent Application Number
157660360
Date Filed
August 4, 2017
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=107801080
Patent Citations
‌
US Patent 10098959 Method for synthesis of reactive conjugate clusters
0
‌
US Patent 10130651 RNAi Therapy for Hepatitis B Virus Infection
0
‌
US Patent 10131907 Glycoconjugates of RNA interference agents
0
‌
US Patent 10246709 Targeting ligands for therapeutic compounds
0
‌
US Patent 10294474 Targeting ligands
0
‌
US Patent 10351852 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
0
‌
US Patent 10590418 Methods and compositions for RNAi mediated inhibition of gene expression in mammals
0
Patent Primary Examiner
‌
J. E. Angell
0
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 26 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 25 Sep, 2022

Find more entities like US Patent 10780108 RNAi agents for Hepatitis B virus infection

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.